Items where authors include "Barrett, J."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Agarwal, G., Moore, S., Sadler, R. et al. (21 more authors) (2024) Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma. Haematologica. ISSN 0390-6078

Cooper, S.J.G. orcid.org/0000-0002-3229-3026, Allen, S.R., Gailani, A. orcid.org/0000-0003-2163-6211 et al. (4 more authors) (2024) Meeting the costs of decarbonising industry – The potential effects on prices and competitiveness (a case study of the UK). Energy Policy, 184. 113904. ISSN 0301-4215

Betts-Davies, S. orcid.org/0000-0001-5682-4103, Barrett, J., Brockway, P. et al. (1 more author) (2023) Is all inequality reduction equal? Understanding motivations and mechanisms for socio-economic inequality reduction in economic narratives of climate change mitigation. Energy Research and Social Science, 107. 103349. ISSN 2214-6296

Caley, L.R. orcid.org/0000-0001-8957-1018, Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Smith, L. orcid.org/0000-0002-4280-6323 et al. (11 more authors) (2023) Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis. Journal of Cystic Fibrosis, 22 (6). pp. 1002-1009. ISSN 1569-1993

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Twumasi, C. orcid.org/0000-0001-6817-8356, Moore, S. orcid.org/0000-0003-1380-1934, Sadler, R. orcid.org/0000-0003-2250-670X et al. (20 more authors) (2023) Determinants of durable humoral and T cell immunity in myeloma patients following <scp>COVID</scp>‐19 vaccination. European Journal of Haematology. ISSN 0902-4441

Forestier-Zhang, L., Watts, L., Turner, A. et al. (8 more authors) (2016) Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia. Orphanet Journal of Rare Diseases, 11. 160.

Javaid, M.K., Forestier-Zhang, L., Watts, L. et al. (15 more authors) (2016) The RUDY study platform – a novel approach to patient driven research in rare musculoskeletal diseases. Orphanet Journal of Rare Diseases, 11 (1). 150. ISSN 1750-1172

Acquaye, A., Genovese, A., Barrett, J. et al. (1 more author) (2014) Benchmarking carbon emissions performance in supply chains. Supply Chain Management: An International Journal, 19 (3). pp. 306-321. ISSN 1359-8546

Turner, K., Lenzen, M., Wiedmann, T. et al. (1 more author) (2007) Examining the Global Environmental Impact of Regional Consumption Activities - Part 1: A Technical Note on Combining Input-Output and Ecological Footprint Analysis. Ecological Economics, 62 (1). pp. 37-44. ISSN 0921-8009

Collins, A., Flynn, A., Wiedmann, T. et al. (1 more author) (2006) The environmental impacts of consumption at a subnational level: the ecological footprint of Cardiff. Journal of Industrial Ecology, 10 (3). pp. 9-24. ISSN 1088-1980

Wiedmann, T., Minx, J., Barrett, J. et al. (1 more author) (2006) Allocating Ecological Footprints to Final Consumption Categories with Input-Output Analysis. Ecological Economics, 56 (1). pp. 28-48. ISSN 0921-8009

Proceedings Paper

Williams, C.J.M., Elliott, F., Shires, M. et al. (58 more authors) (2023) Association between artificial intelligence- (AI) assisted tumour AREG and EREG immunohistochemistry (IHC) and outcomes from anti-EGFR therapy during the routine management of metastatic colorectal cancer (mCRC): an observational cohort study. In: The Journal of Pathology. 5th Joint Meeting with the Royal Society of Medicine, 214th Scientific Meeting of the Pathological Society of Great Britain & Ireland, 23 Jan - 02 Feb 2023, London, UK. Wiley , S16-S16.

Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.